These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 2412532)

  • 1. [Efficacy of tranilast administration and specific hyposensitization therapy of atopic dermatitis].
    Gondo A; Saeki N; Yamamoto E; Hirabayashi T; Tokuda Y
    Arerugi; 1985 May; 34(5):310-9. PubMed ID: 2412532
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of a specific oral hyposensitization therapy to Dermatophagoides pteronyssinus in children with atopic dermatitis.
    Galli E; Chini L; Nardi S; Benincori N; Panei P; Fraioli G; Moschese V; Rossi P
    Allergol Immunopathol (Madr); 1994; 22(1):18-22. PubMed ID: 8030579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The efficacy of long-term specific immunotherapy for Dermatophagoides pteronyssinus in patients with atopic dermatitis].
    Pacor ML; Biasi D; Maleknia T
    Recenti Prog Med; 1994 May; 85(5):273-7. PubMed ID: 8023005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Significance of blocking antibodies in the mechanism of specific desensitization therapy in patients with diffuse neurodermatitis].
    Kalamkarian AA; Samsonov VA; Nurmukhambetov ZhN
    Vestn Dermatol Venerol; 1984 May; (5):8-12. PubMed ID: 6741271
    [No Abstract]   [Full Text] [Related]  

  • 5. [Efficacy of specific immunotherapy in the treatment of children and youngsters suffering from atopic dermatitis Part II. Evaluation of skin reactivity and concentration of serum antigen specific immunoglobulin E directed against selected airborne allergens].
    Silny W; Czarnecka-Operacz M; Silny P
    Wiad Lek; 2005; 58(3-4):184-92. PubMed ID: 16119162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Atopic dermatitis in children (author's transl)].
    Erdmann G
    Monatsschr Kinderheilkd; 1981 Jan; 129(1):4-12. PubMed ID: 6116179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ebm and future direction of allergen-specific immunotherapy for atopic dermatitis].
    Mihara S; Hide M
    Arerugi; 2008 May; 57(5):499-506. PubMed ID: 18520169
    [No Abstract]   [Full Text] [Related]  

  • 8. Non-specific immunotherapy and specific hyposensitization in severe atopic dermatitis.
    Zachariae H; Cramers M; Herlin T; Jensen J; Kragballe K; Ternowitz T; Thestrup-Pedersen K
    Acta Derm Venereol Suppl (Stockh); 1985; 114():48-54. PubMed ID: 3859167
    [No Abstract]   [Full Text] [Related]  

  • 9. Specific hyposensitization in atopic dermatitis.
    Di Prisco de Fuenmayor MC; Champion RH
    Br J Dermatol; 1979 Dec; 101(6):697-700. PubMed ID: 534616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of atopic dermatitis with a combination of allergen-specific immunotherapy and a histamine-immunoglobulin complex.
    Nahm DH; Lee ES; Park HJ; Kim HA; Choi GS; Jeon SY
    Int Arch Allergy Immunol; 2008; 146(3):235-40. PubMed ID: 18268392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Specific hyposensitizing therapy of dermatoses with soluble bacterial allergens].
    Nureev GG
    Vestn Dermatol Venerol; 1982 Jul; (7):52-6. PubMed ID: 7136256
    [No Abstract]   [Full Text] [Related]  

  • 12. Future perspectives in the treatment of atopic dermatitis.
    Katoh N
    J Dermatol; 2009 Jul; 36(7):367-76. PubMed ID: 19583684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunotherapy by Japanese cedarpollen in atpic dermatitis].
    Juji F; Kobayashi S; Ito S; Sugawara N; Kano H; Yasueda H; Iwata T
    Arerugi; 2003 Nov; 52(11):1081-8. PubMed ID: 14685040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Specific immunotherapy in the treatment of patients with atopic dermatitis--results of double blind placebo controlled study].
    Silny W; Czarnecka-Operacz M
    Pol Merkur Lekarski; 2006 Dec; 21(126):558-65. PubMed ID: 17405298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustained benefit of interferon-alpha therapy and oral hyposensitization in severe atopic dermatitis.
    Michils A; Farber CM; Van Vooren JP; Yernault JC; Duchateau J
    Br J Dermatol; 1994 Jan; 130(1):134-5. PubMed ID: 8305310
    [No Abstract]   [Full Text] [Related]  

  • 16. The effects of long term Tranilast administration on bronchial hypersensitivity in asthmatics.
    Suzuki H; Tanaka K; Kaneshige H; Nakagami K; Noguchi E
    Panminerva Med; 1989; 31(2):88-93. PubMed ID: 2477786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experience with hyposensitization.
    Schultz K; Nagylaki T
    J Am Vet Med Assoc; 1990 Jun; 196(12):1910-1. PubMed ID: 2365614
    [No Abstract]   [Full Text] [Related]  

  • 18. Specific hyposensitization for atopic dermatitis: a new era?
    Saurat JH
    Dermatologica; 1991; 182(2):71-2. PubMed ID: 2050236
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical aspects and therapy of atopic dermatitis].
    Baumgartner A; Schöpf E
    Krankenpfl J; 1986 May; 24(5):30-3. PubMed ID: 3638422
    [No Abstract]   [Full Text] [Related]  

  • 20. [Experiences with Bencard's specific "desensitizing" vaccine treatment in allergic skin diseases].
    Korossy S; Vincze E; Csizér Z; Juhász VP
    Dermatol Monatsschr; 1973 Feb; 159(2):110-21. PubMed ID: 4633852
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.